The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status:
Recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy, safety, and durability of two different
strategies to treat participants with a history of sub-optimal adherence and control of their
HIV infection: long-acting (LA) antiretroviral therapy (ART) and all-oral standard of care
(SOC).
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)